Selective Serotonin Reuptake Inhibitors (SSRIs) are types of antidepressants. Brand names of SSRIs include: Paxil, Zoloft, Celexa, Prozac, Lexapro, Symbyax, Wellbutrin and Effexor. These drugs inhibit neuronal serotonin and norepinephrine reuptake and slightly inhibit dopamine reuptake. SSRIs have been associated with serious, life-threatening birth defects. Research suggests that, if a mother took SSRI’s during pregnancy, […]
SC AG Files Lawsuit Against GSK for Improper Marketing of Diabetes Drug
June 3, 2011
Drug Regulators in the US and Europe Restrict Use of Avandia (rosiglitazone)
September 23, 2010
NHTSA Raises Number of Deaths Associated with Toyota Acceleration
May 26, 2010
Toyota Pays $16.4 Million Fine
May 19, 2010
Toyota Announces Plan to Replace Accelerators in Secondary Recall
March 23, 2010
DePuy Orthopaedics ASR Hip Replacement Recall
A DePuy Orthopaedics (Subsidiary of Johnson & Johnson) ASR hip replacement recall was issued for two DePuy Orthopaedics hip replacement products:
-
the ASR Hip Resurfacing System
-
the ASR XL Acetabular System
after data indicated that 12% (one in eight patients) may fail within five years, requiring painful revision hip replacement surgery.
The DePuy ASR Hip Implant System is a metal-on-metal design, which is viewed as less than optimal because, in time, the metal parts can wear, causing small particles of metal to shed into the body. This metal ion release damages tissue, causes pseudotumors and results in osteolysis, requiring hip revision surgery to remove and replace the DePuy ASR hip device. This may happen shortly after the DePuy ASR hip replacement is implanted, or it may take years to occur.
Symptoms include pain, swelling and problems walking. The recall followed concern of orthopedic experts indicating that a design flaw in the DePuy ASR hip replacement increases the risk of complications such as unexplained hip pain, thigh or groin pain, swelling around the hip, pain in standing up from a seated position, pain with weight bearing and pain with walking.
Adverse Event Reports submitted to the FDA mention instances of loosening, pseudotumor and metalosis. Each of the metal hip replacement products are meant to restore worn or weakened parts of the hip, more specifically, the socket at the outer portion of the pelvis and the rounded bone on top of the thigh bone that fits into the socket. Both ASR products have been implanted in the United States since 2005 and have now been discontinued by DePuy Orthopaedics.
Please note that explanted DePuy ASR hip replacement devices are valuable evidence. A patient may not be able to prove a defective product case without it. Patients should be aware of this and should not sign any documents for DePuy Orthopaedics without first consulting an attorney.
If you or a family member received a DePuy ASR Hip Replacment and had to undergo revision surgery or notice any symptoms, you may have a claim against DePuy Orthopaedics (a subsidiary of Johnson & Johnson).
One of our experienced pharmaceutical attorneys would be pleased to assist you in seeking legal remedies. Please complete the short form below or call us at 1-800-642-5297 for a free, confidential consultation at a time convenient for you.